Affiliation:
1. Department of Molecular Medicine and Genetics, Research Center for Molecular Medicine, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2. Vice-Chancellor's Department for Research and Technology, Hamedan University of Medical Sciences, Iran
Abstract
Mesenchymal Stem Cells (MSCs) are one of the most promising tools for cell therapy,
that are isolated from bone marrow and many other adult tissues such as liver, cord blood, placenta,
dental pulp and adipose tissue. Due to the lack of MHC class II expression on the surface of
MSCs, they can also be used as a potent cell source for tissue regeneration in non-autologous cell
therapy applications. Many advantages of MSCs such as their self-renewal, in vitro proliferation,
rapid cell doubling capacity, anti-fibrotic, anti-apoptotic, anti-inflammatory, immunomodulatory
and immunosuppressive effects, and also paracrine nature have been demonstrated in various pre--
clinical studies and clinical evidence. The ability of MSCs to differentiate into multiple cell lineages,
as well as the lack of ethical issues in comparison with embryonic and induced Pluripotent
Stem Cells (iPSCs), has introduced them as a suitable candidate for cell therapy. This review provides
a comprehensive overview of various clinical trials based on MSCs for the treatment of a variety
of diseases, demonstrating their capability in the treatment of dermatological, musculoskeletal,
neurological, cardiovascular, respiratory, renal, gastroenterological and urological conditions, etc.
Publisher
Bentham Science Publishers Ltd.
Subject
General Medicine,Medicine (miscellaneous)
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献